ArticleTherapeutic advances in medical oncology2022

Erratum to "Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.